R. Morishita et al., OLIGONUCLEOTIDE-BASED GENE-THERAPY FOR CARDIOVASCULAR-DISEASE, CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 36(8), 1998, pp. 529-534
Gene therapy is emerging as a potential strategy for the treatment of
cardiovascular disease such as restenosis after angioplasty, vascular
bypass graft occlusion, transplant coronary vasculopathy, homozygous f
amilial hypercholesterolemia and cystic fibrosis, for which no known e
ffective therapy exists. Gene therapy requires efficient in vivo gene
transfer technology. During the past decade, many gene transfer method
s including viral transfer techniques have been developed, and some ar
e being applied clinically in human gene therapy studies. Molecular bi
ology and pathophysiology of the cardiovascular system have started to
emerge, and the time is ripe for the introduction of gene therapy to
the management of cardiovascular disorders. In this review, we have fo
cused on the future potential of oligonucleotide-based gene therapy fa
r the treatment of cardiovascular disease.